NCT03410966View on ClinicalTrials.gov

Atrial Fibrillation Ablation

NACompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

January 1, 2017

Study Completion Date

November 1, 2017

Conditions

Atrial FibrillationHeart Failure, Diastolic

Interventions

PROCEDURE

trans cateheter ablation

All AF patients will receive trans catheter ablation by radiofrequency, to destroy arrhythmic atrial cells, and to isolate arrhythmic atrial firing around pulmonary veins' ostia.

Trial Locations (1)

80128

Raffaele Marfella, Naples

All Listed Sponsors

lead

University of Campania Luigi Vanvitelli

OTHER

NCT03410966 - Atrial Fibrillation Ablation | Biotech Hunter | Biotech Hunter